Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

#RemoteDetailing

- PMLiVE

Janssen’s single tablet Symtuza gains NHS England funding 

Janssen and Gilead combination first to reach patients

- PMLiVE

Checkpoint inhibitor scientists win Nobel Prize

Winners Allison and Honjo inspired efforts to eliminate tumour cells efficiently

Hannah – Celebrating Ten Magical Years at Lucid Group

Given that Lucid Group is only 11 years old itself, it’s a special occasion for the company to recognise significant Lucid anniversaries, especially for those with a decade of service...

Lucid Group Communications Limited

The dark side of direct-to-consumer genetic tests

Direct-to-consumer testing is an affordable way to better understand your DNA, but is this a leap forward in innovation or another layer clouding an already complex market? From anxious patients...

Blue Latitude Health

- PMLiVE

Pfizer names next CEO as Read retires

Company's board elects current chief operating officer Dr Albert Bourla

- PMLiVE

Novo Nordisk to launch connected insulin pens

Also partners with Dexcom, Glooko and Roche on digital platforms

- PMLiVE

China’s Innovent to start US trials of anti-CD47 cancer drug

Sintilimab will be initially positioned for the Chinese market

- PMLiVE

Insmed claims first FDA okay for limited population antibiotic

Arikayce is cleared to treat lung disease caused by MAC

Porterhouse BPS logo

Behaviour change: Five things you probably suspected, but weren’t sure about…

Fabrice Allum, managing director of Porterhouse Insights, looks at behaviour change and introduces the Porterhouse BPS.

Porterhouse Medical Group

- PMLiVE

Bayer to challenge Avastin legal ruling

Both sides claim to be acting in patients' best interest

- PMLiVE

Geron poleaxed as partner J&J abandons only pipeline drug

Shares drop by two-thirds as questions raised on imetelstat’s potential

- PMLiVE

FDA approval gained, Pfizer sets sights on first-line NSCLC market

Vizimpro could challenge Tagrisso, survival data will be key

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links